Correlation Between Lipocine and 47233JDK1
Specify exactly 2 symbols:
By analyzing existing cross correlation between Lipocine and US47233JDK16, you can compare the effects of market volatilities on Lipocine and 47233JDK1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of 47233JDK1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and 47233JDK1.
Diversification Opportunities for Lipocine and 47233JDK1
Very weak diversification
The 3 months correlation between Lipocine and 47233JDK1 is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and US47233JDK16 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US47233JDK16 and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with 47233JDK1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US47233JDK16 has no effect on the direction of Lipocine i.e., Lipocine and 47233JDK1 go up and down completely randomly.
Pair Corralation between Lipocine and 47233JDK1
Given the investment horizon of 90 days Lipocine is expected to generate 2.06 times more return on investment than 47233JDK1. However, Lipocine is 2.06 times more volatile than US47233JDK16. It trades about 0.08 of its potential returns per unit of risk. US47233JDK16 is currently generating about 0.04 per unit of risk. If you would invest 263.00 in Lipocine on September 12, 2024 and sell it today you would earn a total of 257.00 from holding Lipocine or generate 97.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 44.76% |
| Values | Daily Returns |
Lipocine vs. US47233JDK16
Performance |
| Timeline |
| Lipocine |
| US47233JDK16 |
Lipocine and 47233JDK1 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipocine and 47233JDK1
The main advantage of trading using opposite Lipocine and 47233JDK1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, 47233JDK1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 47233JDK1 will offset losses from the drop in 47233JDK1's long position.| Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
| 47233JDK1 vs. NETGEAR | 47233JDK1 vs. Lipocine | 47233JDK1 vs. Franklin Credit Management | 47233JDK1 vs. Stepstone Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |